dazoxiben has been researched along with Injury, Myocardial Reperfusion in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (50.00) | 18.7374 |
1990's | 1 (50.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Ambrosio, G; Chiariello, M; Condorelli, M; de Clerk, F; Focaccio, A; Golino, P; Pace, L; Ragni, M; Villari, B | 1 |
Farber, NE; Gross, GJ; Pieper, GM | 1 |
2 other study(ies) available for dazoxiben and Injury, Myocardial Reperfusion
Article | Year |
---|---|
Endogenous prostaglandin endoperoxides may alter infarct size in the presence of thromboxane synthase inhibition: studies in a rabbit model of coronary artery occlusion-reperfusion.
Topics: Animals; Aspirin; Bridged Bicyclo Compounds, Heterocyclic; Fatty Acids, Unsaturated; Female; Hydrazines; Imidazoles; Male; Myocardial Infarction; Myocardial Reperfusion Injury; Pentanoic Acids; Platelet Aggregation; Prostaglandin Endoperoxides; Prostaglandin Endoperoxides, Synthetic; Pyridines; Rabbits; Receptors, Thromboxane; Thromboxane-A Synthase | 1993 |
Metabolic protection of the reperfused canine endocardium by the thromboxane synthetase inhibitor, dazoxiben.
Topics: Adenine Nucleotides; Adenosine Triphosphate; Animals; Coronary Circulation; Dogs; Epoprostenol; Imidazoles; Myocardial Contraction; Myocardial Reperfusion; Myocardial Reperfusion Injury; Myocardium; Thromboxane A2; Thromboxane-A Synthase | 1988 |